Injective Eyes $70 Post-Washington Meetings

Injective Pursues Regulatory Engagement in Washington Amidst Token Price Recovery Efforts

Injective, a blockchain protocol focused on decentralized finance, is actively engaging with U.S. financial regulators while its native token, INJ, shows signs of a potential recovery. The project’s leadership recently met with officials from the White House, the Securities and Exchange Commission (SEC), and the Commodity Futures Trading Commission (CFTC) to discuss its ambitions for regulatory and financial infrastructure.

High-Level Discussions on Tokenization and Onchain Finance

Injective announced that its CEO, Eric Chen, along with the project’s general counsel, head of policy, and head of research, held meetings with U.S. officials this month. These discussions are part of Injective’s broader strategy to establish a robust regulatory framework for tokenization and onchain finance within the United States. The project highlighted existing achievements, such as Injective Institutional Services being an SEC-registered transfer agent for tokenized securities and INJ futures being listed on CFTC-regulated U.S. markets, underscoring its commitment to integrating with established financial infrastructure.

Institutional Positioning and Market Speculation

Injective is developing institutional-grade infrastructure designed to bring tokenized stocks, funds, and real-world assets onto the blockchain. The project’s legal and policy teams are also actively collaborating with U.S. lawmakers and regulators on digital asset regulation. While these developments are seen as strengthening Injective’s institutional appeal, analysts caution that regulatory progress does not automatically guarantee increased token demand or price appreciation. Investors are advised to differentiate between the project’s fundamental progress and market speculation.

Technical Outlook for INJ Token

From a technical perspective, the INJ token is currently trading around $7.64. The $6.52 level is identified as a critical support for the bullish recovery scenario. A sustained hold above this level would keep the immediate resistance at $15.81 in focus, followed by $33.09. A confirmed breakout above the previous high of approximately $53 could potentially pave the way for a move towards the $70 mark. Conversely, a weekly breakdown below $6.52 would undermine the bullish outlook, rendering the $70 target highly speculative. The current INJ price prediction hinges on both price action confirmation and the ongoing regulatory developments.